Expression of complement components and inhibitors on platelet microparticles

References

• Franchini M, Veneri D, Lippi G. Inflammation and hemostasis: A bidirectional interaction. Clin Lab 2007; 53: 63–67
   PubMed Web of Science ®Google Scholar
• Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1: 1343–1348
   PubMed Web of Science ®Google Scholar
• Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000; 11: 723–728
   PubMed Web of Science ®Google Scholar
• Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425–434
   PubMed Web of Science ®Google Scholar
• Piccin A, Murphy WG, Smith OP. Circulating microparticles: Pathophysiology and clinical implications. Blood Rev 2007; 21: 157–171
   PubMed Web of Science ®Google Scholar
• Choudhury A, Chung I, Blann AD, Lip GY. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: Relationship to p-selectin and antithrombotic therapy. Chest 2007; 131: 809–815
   PubMed Web of Science ®Google Scholar
• Tan KT, Lip GY. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005; 94: 488–492
   PubMed Web of Science ®Google Scholar
• Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: New players in the field of vascular disease?. Eur J Clin Invest 2004; 34: 392–401
   PubMed Web of Science ®Google Scholar
• Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641–2648
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277–287
   PubMed Web of Science ®Google Scholar
• Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: A disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11: 156–164
   PubMedGoogle Scholar
• Gawaz M, Ott I, Reininger AJ, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Arterioscler Thromb Vasc Biol 1996; 16: 621–627
   PubMed Web of Science ®Google Scholar
• George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340–348
   PubMed Web of Science ®Google Scholar
• Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005; 288: H1004–H1009
   Web of Science ®Google Scholar
• Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136–144
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost 2006; 4: 2035–2042
   PubMed Web of Science ®Google Scholar
• Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201: 871–879
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Murphy TK, Ghebrehiwet B. Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost 2003; 89: 331–339
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Peerschke EI. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 2004; 41: 173–183
   PubMed Web of Science ®Google Scholar
• Sims PJ, Rollins SA, Wiedmer T. Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. J Biol Chem 1989; 264: 19228–19235
   PubMed Web of Science ®Google Scholar
• Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171: 715–727
   PubMed Web of Science ®Google Scholar
• Bhakdi S. Complement and atherogenesis: The unknown connection. Ann Med 1998; 30: 503–507
   PubMed Web of Science ®Google Scholar
• Weiser MR, Williams JP, Moore FD, Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996; 183: 2343–2348
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Smyth SS, Teng EI, Dalzell M, Ghebrehiwet B. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. J Immunol 1996; 157: 4154–4158
   PubMed Web of Science ®Google Scholar
• Bode AP, Hickerson DH. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 2000; 11: 259–271
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Lu PD, Zhang W, Lim BL, Eggleton P, Leigh LE, Reid KB, Peerschke EI. Identification of functional domains on gC1q-R, a cell surface protein that binds to the globular “heads” of C1q, using monoclonal antibodies and synthetic peptides. Hybridoma 1996; 15: 333–342
   PubMedGoogle Scholar
• Peerschke EI, Grant RA, Zucker MB. Decreased association of 45calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation. Br J Haematol 1980; 46: 247–256
   PubMed Web of Science ®Google Scholar
• Steinhubl SR. Platelets as mediators of inflammation. Hematol Oncol Clin North Am 2007; 21: 115–121
   PubMed Web of Science ®Google Scholar
• Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemost 2005; 3: 2081–2088
   PubMed Web of Science ®Google Scholar
• Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95: 1694–1702
   PubMed Web of Science ®Google Scholar
• Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: Strangers or partners in crime?. Trends Immunol 2007; 28: 184–192
   PubMed Web of Science ®Google Scholar
• Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, et al. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med 2006; 12: 682–687
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006; 36: 182–187
   PubMed Web of Science ®Google Scholar
• Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996; 157: 1693–1698
   PubMed Web of Science ®Google Scholar
• Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 2003; 17: 1003–1014
   PubMed Web of Science ®Google Scholar
• Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512–1518
   PubMed Web of Science ®Google Scholar
• Tschopp J, Jenne DE, Hertig S, Preissner KT, Morgenstern H, Sapino AP, French L. Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha granules. Blood 1993; 82: 118–125
   PubMed Web of Science ®Google Scholar
• Gnatenko DV, Dunn JJ, McCorkel SR, Weissmann D, Oerritta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285–2293
   PubMed Web of Science ®Google Scholar
• Perez-Pujol S, Martines MB, Higgins LA, Lesestuen GL, Key NS. Proteomic analysis of platelets and platelet-derived microparticles by iTRAQ Laser Spectrometry. J Thromb Haemost 2005; 3[S1]: 1–9
   Google Scholar
• Schmaier AH, Amenta S, Xiong T, Heda GD, Gewirtz AM. Expression of platelet C1 inhibitor. Blood 1993; 82: 465–474
   PubMed Web of Science ®Google Scholar
• Cai S, Davis III AE. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol 2003; 171: 4786–4791
   PubMed Web of Science ®Google Scholar
• Kilgore KS, Flory CM, Miller BF, Evans VM, Warren JS. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 1996; 149: 953–961
   PubMed Web of Science ®Google Scholar
• Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: Roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 2003; 992: 56–71
   PubMed Web of Science ®Google Scholar
• Niculescu F, Rus H. The role of complement activation in atherosclerosis. Immunol Res 2004; 30: 73–80
   PubMed Web of Science ®Google Scholar
• Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, Matis LA, Squinto SP, Rollins SA. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 1995; 96: 1564–1572
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock 2004; 21: 401–409
   PubMed Web of Science ®Google Scholar
• Makrides SC. Therapeutic inhibition of the complement system. Pharmacol Rev 1998; 50: 59–87
   PubMed Web of Science ®Google Scholar
• Niculescu F, Rus H. Complement activation and atherosclerosis. Mol Immunol 1999; 36: 949–955
   PubMed Web of Science ®Google Scholar
• Vlaicu R, Niculescu F, Rus HG, Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985; 57: 163–177
   PubMed Web of Science ®Google Scholar
• Laine P, Pentikainen MO, Wurzner R, Penttila A, Paavonen T, Meri S, Kovanen PT. Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J Cardiol 2002; 90: 404–408
   PubMed Web of Science ®Google Scholar
• Speidl WS, Exner M, Amighi J, Kastl SP, Zorn G, Maurer G, Wagner O, Huber K, Minar E, Wojta J, et al. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 2005; 26: 2294–2299
   PubMed Web of Science ®Google Scholar